Condition
Opioid Tolerance
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.6% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 3 (1)
Trial Status
Completed3
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06488768Not ApplicableCompleted
Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study
NCT00618397Phase 1Terminated
Pharmacokinetics of Low Dose Ketamine Infusion
NCT01553435Not ApplicableUnknown
Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients
NCT00669175CompletedPrimary
Safety and Efficacy of a Low Dose Naloxone Infusion in NICU Patients
NCT00286052Phase 3CompletedPrimary
Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU Patients
Showing all 5 trials